These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 21998584)

  • 1. Chlamydia trachomatis co-opts the FGF2 signaling pathway to enhance infection.
    Kim JH; Jiang S; Elwell CA; Engel JN
    PLoS Pathog; 2011 Oct; 7(10):e1002285. PubMed ID: 21998584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host nectin-1 is required for efficient Chlamydia trachomatis serovar E development.
    Hall JV; Sun J; Slade J; Kintner J; Bambino M; Whittimore J; Schoborg RV
    Front Cell Infect Microbiol; 2014; 4():158. PubMed ID: 25414835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
    Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
    Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast Growth Factor-2 Binding to Heparan Sulfate Proteoglycans Varies with Shear Stress in Flow-Adapted Cells.
    Garcia J; Patel N; Basehore S; Clyne AM
    Ann Biomed Eng; 2019 Apr; 47(4):1078-1093. PubMed ID: 30689065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly.
    Ibrahimi OA; Zhang F; Hrstka SC; Mohammadi M; Linhardt RJ
    Biochemistry; 2004 Apr; 43(16):4724-30. PubMed ID: 15096041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists.
    Presta M; Oreste P; Zoppetti G; Belleri M; Tanghetti E; Leali D; Urbinati C; Bugatti A; Ronca R; Nicoli S; Moroni E; Stabile H; Camozzi M; Hernandez GA; Mitola S; Dell'Era P; Rusnati M; Ribatti D
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):71-6. PubMed ID: 15514208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlamydia exploits filopodial capture and a macropinocytosis-like pathway for host cell entry.
    Ford C; Nans A; Boucrot E; Hayward RD
    PLoS Pathog; 2018 May; 14(5):e1007051. PubMed ID: 29727463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The
    Herrera CM; McMahon E; Swaney DL; Sherry J; Pha K; Adams-Boone K; Johnson JR; Krogan NJ; Stevers M; Solomon D; Elwell C; Engel J
    Microbiol Spectr; 2024 Jul; 12(7):e0045324. PubMed ID: 38814079
    [No Abstract]   [Full Text] [Related]  

  • 9. Host-pathogen reorganisation during host cell entry by Chlamydia trachomatis.
    Nans A; Ford C; Hayward RD
    Microbes Infect; 2015; 17(11-12):727-31. PubMed ID: 26320027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EphrinA2 receptor (EphA2) is an invasion and intracellular signaling receptor for Chlamydia trachomatis.
    Subbarayal P; Karunakaran K; Winkler AC; Rother M; Gonzalez E; Meyer TF; Rudel T
    PLoS Pathog; 2015 Apr; 11(4):e1004846. PubMed ID: 25906164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of affinity purification-mass spectrometry experimental systems used to identify eukaryotic and chlamydial proteins at the Chlamydia trachomatis inclusion membrane.
    Olson MG; Ouellette SP; Rucks EA
    J Proteomics; 2020 Feb; 212():103595. PubMed ID: 31760040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Proteome of the Isolated Chlamydia trachomatis Containing Vacuole Reveals a Complex Trafficking Platform Enriched for Retromer Components.
    Aeberhard L; Banhart S; Fischer M; Jehmlich N; Rose L; Koch S; Laue M; Renard BY; Schmidt F; Heuer D
    PLoS Pathog; 2015 Jun; 11(6):e1004883. PubMed ID: 26042774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Chlamydia trachomatis type III secretion chaperone Slc1 engages multiple early effectors, including TepP, a tyrosine-phosphorylated protein required for the recruitment of CrkI-II to nascent inclusions and innate immune signaling.
    Chen YS; Bastidas RJ; Saka HA; Carpenter VK; Richards KL; Plano GV; Valdivia RH
    PLoS Pathog; 2014 Feb; 10(2):e1003954. PubMed ID: 24586162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydiaphage φCPG1 Capsid Protein Vp1 Inhibits Chlamydia trachomatis Growth via the Mitogen-Activated Protein Kinase Pathway.
    Guo Y; Guo R; Zhou Q; Sun C; Zhang X; Liu Y; Liu Q
    Viruses; 2016 Apr; 8(4):99. PubMed ID: 27089359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Active Metabolism on Chlamydia trachomatis Elementary Body Transcript Profile and Infectivity.
    Grieshaber S; Grieshaber N; Yang H; Baxter B; Hackstadt T; Omsland A
    J Bacteriol; 2018 Jul; 200(14):. PubMed ID: 29735758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling.
    Forsten-Williams K; Chua CC; Nugent MA
    J Theor Biol; 2005 Apr; 233(4):483-99. PubMed ID: 15748910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host and Bacterial Glycolysis during
    Ende RJ; Derré I
    Infect Immun; 2020 Nov; 88(12):. PubMed ID: 32900818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of immunoglobulin G isotype on the infectivity of Chlamydia trachomatis in a mouse model of intravaginal infection.
    Peterson EM; Cheng X; Motin VL; de la Maza LM
    Infect Immun; 1997 Jul; 65(7):2693-9. PubMed ID: 9199438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mcl-1 is a key regulator of apoptosis resistance in Chlamydia trachomatis-infected cells.
    Rajalingam K; Sharma M; Lohmann C; Oswald M; Thieck O; Froelich CJ; Rudel T
    PLoS One; 2008 Sep; 3(9):e3102. PubMed ID: 18769617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiapoptotic activity of Chlamydia trachomatis Pgp3 protein involves activation of the ERK1/2 pathway mediated by upregulation of DJ-1 protein.
    Luo F; Shu M; Gong S; Wen Y; He B; Su S; Li Z
    Pathog Dis; 2019 Dec; 77(9):. PubMed ID: 31971555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.